OncoRedox

Point-of-care Testing Device for Cancer Detection

Health Tech & Life Sciences

Active

Seed Or Yehuda Founded 2022

Website ↗ LinkedIn

Total raised

$890K

Last: Seed 2023-02

Stage

Seed

Founded

2022

Headcount

Or Yehuda

Sector

Health Tech & Life Sciences

About

OncoRedox is developing a Point-of-care testing device for cancer detection based on ‘Redox-omics’ analysis of urine samples. The technology is based on biochemical electrodes detecting redox metabolic signature using an AI analysis model.

Funding history · 1 round · $890K total

2023-02

Seed $890K

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesDiagnostics Devices

Technologies

Artificial IntelligenceBiologicals

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

Name	OncoRedox
Slug	oncoredox
Type	Israeli Startup
Founded	2022
HQ city	Or Yehuda
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	active
Current stage	Seed
Public stage	Seed
Total raised (USD)	890,000
Last round	Seed (2023-02)
Website	https://www.oncoredox.com/
Israeli Companies Registrar	516656998

OncoRedox

About

Funding history · 1 round · $890K total

Sectors & technology

Tags

OncoRedox — Full Company Profile (machine-readable)

About

Facts

Funding rounds (1)

Team (1)

About

Funding history · 1 round · $890K total

Sectors & technology

Tags

Generate Slim Page